Invivyd (IVVD) Return on Capital Employed [ROCE] (2021 - 2026)
Invivyd's Return on Capital Employed [ROCE] came in at -38.95% for Q2 2026, up 179.41 percentage points from -218.35% a year earlier.
Powered by 
Analysis
Invivyd (IVVD) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2025, Invivyd's Return on Capital Employed [ROCE] was -32.87%, up 117.83 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a four-year change of +41.12 percentage points (FY2021 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -150.70% in FY2024 (-67.55 pp), -83.15% in FY2023 (-31.10 pp), -52.04% in FY2022 (+21.95 pp) and -73.99% in FY2021.
- The five-year range for quarterly Return on Capital Employed [ROCE] is -257.32% (Q3 2024) to -31.96% (Q4 2025).
- Year-over-year, Return on Capital Employed [ROCE] increased in three of the last seven quarters, with an average year-over-year change of +6.63 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2026 (a gain of 179.41 percentage points), and the weakest in Q3 2024 (a drop of 188.68 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Invivyd | 241.70 Mn | -264.94 Mn | 13.01 Mn | -38.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.95% |
| Dec 31, 2025 | -31.96% |
| Sep 30, 2025 | -89.35% |
| Jun 30, 2025 | -218.35% |
| Mar 31, 2025 | -220.35% |
| Dec 31, 2024 | -211.21% |
| Sep 30, 2024 | -257.32% |
| Jun 30, 2024 | -134.72% |
| Mar 31, 2024 | -118.17% |
| Dec 31, 2023 | -105.45% |
| Sep 30, 2023 | -68.64% |
| Jun 30, 2023 | -62.73% |
| Mar 31, 2023 | -54.05% |
| Dec 31, 2022 | -65.46% |
| Sep 30, 2022 | -69.25% |
| Jun 30, 2022 | -65.40% |
| Mar 31, 2022 | -58.65% |
| Dec 31, 2021 | -38.39% |
API Access
Invivyd Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IVVD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "IVVD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IVVD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();